TRIAL UPDATE: First patient was enrolled in the EORTC 1945

July 1, 2021

OligoRARE trial in oligometastatic rare cancers OligoRARE is an international study with 6 participating countries in Europe and a collaboration with the British Columbia Cancer Agency in Canada. 

EORTC would like to thank The Anticancer Fund and Rising Tide Group for supporting this trial.

Find out more about how we support the OligoRARE study

More info about the project here 



Scroll to Top